USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of the European Hepatitis B and C Therapeutics Markets
Analysis of the European Hepatitis B and C Therapeutics Markets
Emerging Combinatorial Therapeutics is the Future Market
RELEASE DATE
18-Feb-2013
18-Feb-2013
REGION
North America
North America
Research Code: M8B9-01-00-00-00
SKU: LS00091-NA-MR_16932
$4,950.00
In stock
SKU
LS00091-NA-MR_16932
Description
This research service gives an in-depth analysis of what lies next for the Hepatitis B and C therapeutics markets. This research service covers, the key trends, drivers, restraints, revenue forecasts and competitive analysis of the Hepatitis B and C therapeutics market along with the respective segments such as interferons, nucleoside analogues for Hepatitis B and SOC, protease inhibitors for Hepatitis C. A comprehensive European Regional analysis (The United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia) and regional policy implications have also been provided.
Table of Contents
Executive Summary
Executive Summary—Market Engineering Measurements
Executive Summary—Market Engineering Measurements (continued)
Executive Summary—Market Engineering Measurements (continued)
Executive Summary—Market Engineering Measurements (continued)
Executive Summary—CEO’s Perspective
Market Overview—Disease Overview
Market Overview—Disease Overview (continued)
Market Overview—Hepatitis B Definitions
Market Overview—Key Questions This Study Will Answer
Market Overview—Market Segmentation
Market Overview—Geographic Segmentation
Drivers and Restraints
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Impact Mapping of Drivers and Restraints
Market Engineering Measurements
Market Engineering Measurements (continued)
Forecast Assumptions
Hepatitis B Therapeutics Market—Revenue Forecast
Hepatitis B Therapeutics Market—Revenue Forecast Discussion
Hepatitis B Therapeutics Market—Revenue Forecast by Drug Class
Hepatitis B Therapeutics Market—Revenue Forecast by Region
Hepatitis B Therapeutics Market—Revenue Forecast by Region
HBV Surveillance System
HBV Surveillance System (continued)
Hepatitis B Therapeutics Market—Metrics Analysis
Market Engineering Measurements
Market Engineering Measurements (continued)
Hepatitis C Therapeutics Market—Revenue Forecast
Hepatitis C Therapeutics Market—Revenue Forecast Discussion
Hepatitis C Therapeutics Market—Revenue Forecast by Drug Class
Hepatitis C Therapeutics Market—Revenue Forecast by Region
Hepatitis C Therapeutics Market—Revenue Forecast by Region (continued)
HCV Surveillance System
HCV Surveillance System (continued)
Hepatitis C Therapeutics Market—Metrics Analysis
PEST Analysis
Hepatitis B—Infection Prevalence Analysis
Hepatitis C—Infection Prevalence Analysis
Competitive Analysis—Market Share
Market Share Analysis
Competitive Environment
Competitive Analysis—Market Share
Market Share Analysis
Competitive Environment
Hepatitis B—Key Marketed Product Analysis
Hepatitis B—Key Pipeline Analysis
Hepatitis B—Key Pipeline Analysis (continued)
Hepatitis C—Marketed Product Analysis
Hepatitis C—Marketed Product Analysis (continued)
Hepatitis C—Key Pipeline Analysis Pipeline Analysis
Hepatitis C—Key Pipeline Analysis—Interferon-free Combinations
Interferons Segment Breakdown
Interferons Segment—Market Engineering Measurements
Interferons Segment—Revenue Forecast
Interferons Segment—Revenue Forecast Discussion
Interferons Segment—Impact of Key Market Trends
Nucleoside Analogues Segment Breakdown
Nucleoside Analogues Segment—Market Engineering Measurements
Nucleoside Analogues Segment—Revenue Forecast
Nucleoside Analogues Segment—Revenue Forecast Discussion
Nucleoside Analogues Segment—Impact of Key Market Trends
SOC Segment Breakdown
SOC Segment—Market Engineering Measurements
SOC Segment—Revenue Forecast
SOC Segment—Revenue Forecast Discussion
SOC Segment—Impact of Key Market Trends
Protease Inhibitors Segment Breakdown
Protease Inhibitors Segment—Market Engineering Measurements
Protease Inhibitors Segment—Revenue Forecast
Protease Inhibitors Segment—Revenue Forecast Discussion
Protease Inhibitors Segment—Impact of Key Market Trends
UK Market—Introduction
UK Hepatitis B Therapeutics Market—Market Engineering Measurements
UK Hepatitis B Therapeutics Market—Revenue Forecast
UK Hepatitis C Therapeutics Market—Market Engineering Measurements
UK Hepatitis C Therapeutics Market—Revenue Forecast
UK Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion
UK Hepatitis B and C Therapeutics Markets—Policies and Implications
German Market—Introduction
German Hepatitis B Therapeutics Market—Market Engineering Measurements
German Hepatitis B Therapeutics Market—Revenue Forecast
German Hepatitis C Therapeutics Market—Market Engineering Measurements
German Hepatitis C Therapeutics Market—Revenue Forecast
German Hepatitis B and Hepatitis C Drugs Markets—Revenue Forecast Discussion
German Hepatitis B and Hepatitis C Therapeutics Markets —Policies and Implications
French Market—Introduction
French Hepatitis B Therapeutics Market—Market Engineering Measurements
French Hepatitis B Therapeutics Market—Revenue Forecast
French Hepatitis C Therapeutics Market—Market Engineering Measurements
French Hepatitis C Therapeutics Market—Revenue Forecast
French Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion
French Hepatitis B and C Therapeutics Markets—Policies and Implications
Spanish Market—Introduction
Spanish Hepatitis B Therapeutics Market—Market Engineering Measurements
Spanish Hepatitis B Therapeutics Market—Revenue Forecast
Spanish Hepatitis C Therapeutics Market—Market Engineering Measurements
Spanish Hepatitis C Therapeutics Market—Revenue Forecast
Spanish Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion
Spanish Hepatitis B and C Therapeutics Markets—Policies and Implications
The Italian Market—Introduction
Italian Hepatitis B Therapeutics Market—Market Engineering Measurements
Italian Hepatitis B Therapeutics Market—Revenue Forecast
Italian Hepatitis C Therapeutics Market—Market Engineering Measurements
Italian Hepatitis C Therapeutics Market—Revenue Forecast
Italian Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion
Italian Hepatitis B and C Therapeutics Markets—Policies and Implications
Benelux Market—Introduction
Benelux Hepatitis B Therapeutics Market—Market Engineering Measurements
Benelux Hepatitis B Therapeutics Market—Revenue Forecast
Benelux Hepatitis C Therapeutics Market—Market Engineering Measurements
Benelux Hepatitis C Therapeutics Market—Revenue Forecast
Benelux Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion
Belgium Hepatitis B and C Therapeutics Markets—Policies and Implications
The Netherlands Hepatitis B and C Therapeutics Markets—Policies and Implications (continued)
Luxembourg Hepatitis B and C Therapeutics Markets—Policies and Implications
Scandinavian Market—Introduction
Scandinavia Hepatitis B Therapeutics Market—Market Engineering Measurements
Scandinavia Hepatitis B Therapeutics Market—Revenue Forecast
Scandinavia Hepatitis C Therapeutics Market—Market Engineering Measurements
Scandinavia Hepatitis C Therapeutics Market—Revenue Forecast
Scandinavia Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast Discussion
Norway Hepatitis B and C Therapeutics Markets—Policies and Implications
Denmark Hepatitis B and C Therapeutics Markets—Policies and Implications
Finland Hepatitis B and C Therapeutics Markets—Policies and Implications
Sweden Hepatitis B and C Therapeutics Markets—Policies and Implications
Conclusions—Hepatitis B and C Therapeutics Markets
The Last Word—Three Big Predictions
Legal Disclaimer
Market Engineering Methodology
Database of Key Industry Participants
Additional Sources of Information
Table of Acronyms Used
Incidence of Hepatitis B
Liver Failure Deaths
Government Healthcare Expenditure
Total Healthcare Expenditure
Popular Topics
The marketed and development product landscape for diabetes therapeutics is becoming crowded with multiple products with little differentiation. However, there is still ample room for growth through the introduction of novel therapies that fill therapeutic gaps left by available products. Comprehensive information on market background and global overview and analysis of drug development, detailed product and pipeline analysis by market segment, drug class, and stage of development, and detailed product profiles for key marketed and late-stage products is included in the study. Also included are time-sensitive details such as new product launch timelines, cardiovascular outcomes trials timelines, and patent expirations.
| No Index | Yes |
|---|---|
| Podcast | No |
| Author | Deepika Pramod Chopda |
| WIP Number | M8B9-01-00-00-00 |
| Is Prebook | No |